$NRXP

$2.69 +$0.14 (5.49%) Close

$NRXP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 43.3M shares outstanding

Who owns NRXP?

By type of holder

Institutions 26.9% Insiders 10.8% Everyone else 62.4%

Concentration Top 10 holders own 27.1%

B Group, Inc. 9.5% · Javitt Jonathan C 3.8%

Institutional ownership

26.9%

+12.5 pts vs last qtr

Institutional holders

+14 vs last qtr

Net shares bought

+5.4M

by institutions in Q2 2026

New / sold out

19 / 5

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

B Group, Inc. +1.1M
Ameriprise Financial Inc NEW +928.7K

Biggest sellers in Q2 2026

XTX Topco Ltd −60.2K
Headlands Technologies LLC SOLD OUT −39.4K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for NRX Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2020–FY2022

+91.9%

+38.53% a year

Each share's claim on the business

−47.9%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $12.1M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years32% Under 1 year68%

Quarterly turnover

46.5%

of institutional shares changed hands

Top 10 managers, median time held

2 years

Super Investors

Investment managers reporting NRXP on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
BG B Group, Inc.	4.1M	9.45%	+1.1M (+36.4%)	Q1 '26	7.9%
Shares held by quarter Peak holding4.1M (Q2'26) Change over 8 quarters+4.1M Share of the company9.450% B Group, Inc.'s full portfolio →
VC Vanguard Capital Management LLC	1.6M	3.74%	+458.0K (+39.5%)	2024	0.0%
Shares held by quarter Peak holding1.6M (Q2'26) Change over 8 quarters+1.6M Share of the company3.740% Vanguard Capital Management LLC's full portfolio →

B Group, Inc.

4.1M

% of company

9.45%

Change vs last qtr

+1.1M (+36.4%)

Held since

Q1 '26

Vanguard Capital Management LLC

1.6M

% of company

3.74%

Change vs last qtr

+458.0K (+39.5%)

Held since

2024

28 more super investors behind a free account

See every manager holding NRX Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting NRXP on Form N-PORT; together they hold 6.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$5.18M	1.3M	2.93%	0.00%	June 30, 2026
AP AdvisorShares Psychedelics ETF AdvisorShares Trust	$2.7M	659.0K	1.52%	6.07%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$5.18M

% of company

2.93%

% of the fund

0.00%

As of

June 30, 2026

AdvisorShares Psychedelics ETF

AdvisorShares Trust

Position value

$2.7M

% of company

1.52%

% of the fund

6.07%

As of

June 30, 2026

12 more funds behind a free account

See every fund holding NRX Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
JJ Javitt Jonathan C Insider	1.7M	3.83%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company3.830% Javitt Jonathan C's insider activity →

Javitt Jonathan C

Insider

1.7M

% of company

3.83%

Change vs last qtr

—

Held since

—

Comments